Medical Care

Global CAR T-Cell Immunotherapy Market Research Report 2024

CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
The global CAR T-Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CAR T-Cell Immunotherapy in Hematologic Malignancies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CAR T-Cell Immunotherapy include AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, Gilead, Pfizer, Cellectis and Bellicum, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CAR T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell Immunotherapy.
Report Scope
The CAR T-Cell Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR T-Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR T-Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Hematologic Malignancies
Solid Malignancies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR T-Cell Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global CAR T-Cell Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hematologic Malignancies
1.3.3 Solid Malignancies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Immunotherapy Market Perspective (2019-2030)
2.2 CAR T-Cell Immunotherapy Growth Trends by Region
2.2.1 Global CAR T-Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CAR T-Cell Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 CAR T-Cell Immunotherapy Market Dynamics
2.3.1 CAR T-Cell Immunotherapy Industry Trends
2.3.2 CAR T-Cell Immunotherapy Market Drivers
2.3.3 CAR T-Cell Immunotherapy Market Challenges
2.3.4 CAR T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2023
3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into CAR T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030)
5 CAR T-Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CAR T-Cell Immunotherapy Market Size (2019-2030)
6.2 North America CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
6.4 North America CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell Immunotherapy Market Size (2019-2030)
7.2 Europe CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
7.4 Europe CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell Immunotherapy Market Size (2019-2030)
9.2 Latin America CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene CAR T-Cell Immunotherapy Introduction
11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.2.5 Celgene Recent Development
11.3 Kite Pharma
11.3.1 Kite Pharma Company Detail
11.3.2 Kite Pharma Business Overview
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.3.5 Kite Pharma Recent Development
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Detail
11.4.2 Oxford BioMedica Business Overview
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.4.5 Oxford BioMedica Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis CAR T-Cell Immunotherapy Introduction
11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Gilead
11.6.1 Gilead Company Detail
11.6.2 Gilead Business Overview
11.6.3 Gilead CAR T-Cell Immunotherapy Introduction
11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.6.5 Gilead Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Cellectis
11.8.1 Cellectis Company Detail
11.8.2 Cellectis Business Overview
11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.8.5 Cellectis Recent Development
11.9 Bellicum
11.9.1 Bellicum Company Detail
11.9.2 Bellicum Business Overview
11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.9.5 Bellicum Recent Development
11.10 Mustang Bio
11.10.1 Mustang Bio Company Detail
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.10.5 Mustang Bio Recent Development
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Detail
11.11.2 CARsgen Therapeutics Business Overview
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.11.5 CARsgen Therapeutics Recent Development
11.12 Xyphos
11.12.1 Xyphos Company Detail
11.12.2 Xyphos Business Overview
11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.12.5 Xyphos Recent Development
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Detail
11.13.2 Minerva Biotechnologies Business Overview
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.13.5 Minerva Biotechnologies Recent Development
11.14 Adaptimmune
11.14.1 Adaptimmune Company Detail
11.14.2 Adaptimmune Business Overview
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.14.5 Adaptimmune Recent Development
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Detail
11.15.2 Ziopharm Oncology Business Overview
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.15.5 Ziopharm Oncology Recent Development
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Detail
11.16.2 Aurora Biopharma Business Overview
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.16.5 Aurora Biopharma Recent Development
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Detail
11.17.2 Creative Biolabs Business Overview
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.17.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global CAR T-Cell Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CAR T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global CAR T-Cell Immunotherapy Market Share by Region (2019-2024)
Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global CAR T-Cell Immunotherapy Market Share by Region (2025-2030)
Table 10. CAR T-Cell Immunotherapy Market Trends
Table 11. CAR T-Cell Immunotherapy Market Drivers
Table 12. CAR T-Cell Immunotherapy Market Challenges
Table 13. CAR T-Cell Immunotherapy Market Restraints
Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Market Share by Players (2019-2024)
Table 16. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2023)
Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2019-2024)
Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2025-2030)
Table 27. Global CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2019-2024)
Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2025-2030)
Table 31. North America CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific CAR T-Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie CAR T-Cell Immunotherapy Product
Table 49. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Celgene Company Detail
Table 52. Celgene Business Overview
Table 53. Celgene CAR T-Cell Immunotherapy Product
Table 54. Celgene Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 55. Celgene Recent Development
Table 56. Kite Pharma Company Detail
Table 57. Kite Pharma Business Overview
Table 58. Kite Pharma CAR T-Cell Immunotherapy Product
Table 59. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 60. Kite Pharma Recent Development
Table 61. Oxford BioMedica Company Detail
Table 62. Oxford BioMedica Business Overview
Table 63. Oxford BioMedica CAR T-Cell Immunotherapy Product
Table 64. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 65. Oxford BioMedica Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis CAR T-Cell Immunotherapy Product
Table 69. Novartis Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Gilead Company Detail
Table 72. Gilead Business Overview
Table 73. Gilead CAR T-Cell Immunotherapy Product
Table 74. Gilead Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 75. Gilead Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer CAR T-Cell Immunotherapy Product
Table 79. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Cellectis Company Detail
Table 82. Cellectis Business Overview
Table 83. Cellectis CAR T-Cell Immunotherapy Product
Table 84. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 85. Cellectis Recent Development
Table 86. Bellicum Company Detail
Table 87. Bellicum Business Overview
Table 88. Bellicum CAR T-Cell Immunotherapy Product
Table 89. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 90. Bellicum Recent Development
Table 91. Mustang Bio Company Detail
Table 92. Mustang Bio Business Overview
Table 93. Mustang Bio CAR T-Cell Immunotherapy Product
Table 94. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 95. Mustang Bio Recent Development
Table 96. CARsgen Therapeutics Company Detail
Table 97. CARsgen Therapeutics Business Overview
Table 98. CARsgen Therapeutics CAR T-Cell Immunotherapy Product
Table 99. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 100. CARsgen Therapeutics Recent Development
Table 101. Xyphos Company Detail
Table 102. Xyphos Business Overview
Table 103. Xyphos CAR T-Cell Immunotherapy Product
Table 104. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 105. Xyphos Recent Development
Table 106. Minerva Biotechnologies Company Detail
Table 107. Minerva Biotechnologies Business Overview
Table 108. Minerva Biotechnologies CAR T-Cell Immunotherapy Product
Table 109. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 110. Minerva Biotechnologies Recent Development
Table 111. Adaptimmune Company Detail
Table 112. Adaptimmune Business Overview
Table 113. Adaptimmune CAR T-Cell Immunotherapy Product
Table 114. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 115. Adaptimmune Recent Development
Table 116. Ziopharm Oncology Company Detail
Table 117. Ziopharm Oncology Business Overview
Table 118. Ziopharm Oncology CAR T-Cell Immunotherapy Product
Table 119. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 120. Ziopharm Oncology Recent Development
Table 121. Aurora Biopharma Company Detail
Table 122. Aurora Biopharma Business Overview
Table 123. Aurora Biopharma CAR T-Cell Immunotherapy Product
Table 124. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 125. Aurora Biopharma Recent Development
Table 126. Creative Biolabs Company Detail
Table 127. Creative Biolabs Business Overview
Table 128. Creative Biolabs CAR T-Cell Immunotherapy Product
Table 129. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 130. Creative Biolabs Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CAR T-Cell Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global CAR T-Cell Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global CAR T-Cell Immunotherapy Market Share by Application: 2023 VS 2030
Figure 7. Hematologic Malignancies Case Studies
Figure 8. Solid Malignancies Case Studies
Figure 9. CAR T-Cell Immunotherapy Report Years Considered
Figure 10. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global CAR T-Cell Immunotherapy Market Share by Region: 2023 VS 2030
Figure 13. Global CAR T-Cell Immunotherapy Market Share by Players in 2023
Figure 14. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2023
Figure 16. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 18. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 22. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Region (2019-2030)
Figure 30. China CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 38. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 42. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 45. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 46. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 47. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 49. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 50. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 51. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 52. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 53. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 54. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 55. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 56. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 57. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 58. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 59. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 60. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies